Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Advanced Technologies » HAD-890415
  • Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 – 2023

  • Publish: January 2016 | Report Code: HAD-890415

* For 15% discount/customization and buying a particular chapter click here or write to us at sales@occamsresearh.com

Hybrid operating room is facilitated with advanced medical imaging equipment that provides  interconnectivity through an established communication system. This hybrid operating room market includes various operating devices or imaging devices used in operation theater. The global hybrid operating room market is estimated to grow rapidly in next 5 to 6 years, due to the rising demand of new technologies such as robotics surgery etc. The other major factor which drives this market is the high mortality rate due to CVD and other heart related diseases. The hybrid operating room market has contributed $3510 million in 2015 and is forecasted to grow around $8850 million at a growing CAGR of 16.6% between 2016 and 2022. The report focuses on various technologies and applications of the hybrid operating room market and the factors leading to growth and development of the industry. Asia Pacific region is dominating the hybrid operating room market due to the increasing demand for hybrid operating room devices such as MRI machines, CT scanners etc.

Increasing adoption of technological advancements in APAC is the major factor which drives the hybrid operating room market. The main reason for this is the increasing adoption of robotic surgeries in various countries of this region, such as China, Japan, Korea and Taiwan. Rising support of various end user industries such as medical, government etc. also helps in boosting the hybrid operating room market. The hybrid operating room market is forecasted to grow at higher rate in future due to favorable government policies, rising demand for invasive surgeries and huge investments in various technologies which helps in better healthcare for the patients. Although there are many factors which drive the market, still there are certain challenges which are faced by the market such as, the installation of  hybrid operating room equipments which requires additional space, and is a major challenge for standard hospital room sizes, adversely affecting the market.

The global hybrid operating room market is segmented on the basis of devices, application and by geography. On the basis of devices, the market is segmented into operating tables, operating room lights, surgical rooms, surgical imaging displays, intraoperative diagnostic devices, operating room communication systems etc. The intraoperative diagnostics devices holds the largest share and also act as a major driver for hybrid operating room  market due to the increasing usage of various machines such as 3D ultrasound and MRI. On the basis of application, the market is further segmented into therapeutic, diagnostic imaging etc. Among all the applications, therapeutics hold the largest market share due to increasing demand for cardiovascular operating rooms which helps in curing CVD diseases and fatalities,  and is forecasted to grow in near future due to high demand of medical devices such as robotics surgery etc.

Some of the major players of the market include Barco Nv, Cook Medical, GE healthcare, Johnson & Johnson, Mediflex and so on. Mergers, product launches, innovations and expansions are some of the key strategies adopted by the market players. On 11 April’2016, GE healthcare teamed up with Mayoclinic , to deal with Celltherapy manufacturing invent. On the basis of geography, North America, Europe, Asia Pacific and ROW are the major segments. In which Asia Pacific dominates the hybrid operating room market.

VCHAP 1. EXECUTIVE SUMMARY
 1.1. METHODOLOGY
 
 
CHAP 2. MARKET OVERVIEW
 2.1. DEFINITION
 2.2. KEY FINDINGS
 2.2.1. MARKET OPPORTUNITIES ARE IN ASIA PACIFIC
 2.2.2. CARDIOVASCULAR & NEUROSURGERY DOMINATES THE THERAPEUTIC APPLICATION MARKET
 2.2.3. DEMAND FOR NON INVASIVE SURGERIES IS DRIVING THE MARKET GROWTH
 2.2.4. SURGICAL IMAGING DISPLAY MARKET PROMISING GREAT FUTURE
 2.2.5. IMAGING SYSTEMS WILL HAVE THE HIGHEST MARKET SHARE DRIVEN BY PRESENCE OF MAJOR DIAGNOSTIC IMAGING COMPANIES
 2.2.6. PARTNERSHIPS AND COLLABORATIONS ARE THE WINNING STRATEGIES FOR THE MARKET PLAYERS
 2.3. KEY BUYING CRITERIA
 2.3.1. PATIENT CARE & SAFETY
 2.3.2. PRICE
 2.3.3. SUCCESS RATES
 2.3.4. OPERATING ROOM DESIGN
 2.4. VALUE CHAIN ANALYSIS
 2.5. PLANNING AND ESTABLISHMENT OF HYBRID OPERATING ROOM
 2.5.1. PLANNING
 2.5.2. DESIGN AND CONSTRUCTION
 2.5.3. LOCATION
 2.5.4. IMAGING DEVICES
 2.5.4.1. MOBILE & FIXED SYSTEMS
 2.5.4.2. IMAGE INTENSIFIER AND FLAT PANEL DETECTOR SYSTEM
 2.5.4.3. CEILING AND FLOOR MOUNTED SYSTEMS
 
 
CHAP 3. MARKET DETERMINANTS
 3.1. DRIVERS OF HYBRID OPERATING ROOMS
 3.1.1. HEALTHCARE REFORMS  ADVANCEMENTS IN HEALTHCARE TECHNOLOGIES DRIVE PRODUCT INNOVATION
 3.1.2. BENEFITS OVER CONVENTIONAL OPERATING SYSTEMS DRIVE ADOPTION
 3.1.2.1. HYBRID OR PROVIDES MAXIMUM FLEXIBILITY
 3.1.2.2. CLINICAL DECISION SUPPORT SYSTEMS
 3.1.3. INCREASING NUMBER OF ASCS (AMBULATORY SURGICAL CENTERS)
 3.1.4. DECREASING MORTALITY AND MORBIDITY DEMANDS FOR A SAFER OPERATING ENVIRONMENT
 3.1.5. GROWING NUMBER OF HEART PATIENTS GLOBALLY
 3.1.6. HYBRID APPROACH TO MINIMALLY INVASIVE HEART SURGERY
 3.1.7. SMART HEALTHCARE WILL DRIVE FASTER ADOPTION
 3.1.8. GLOBAL INCREASE IN HEALTHCARE SPENDING
 3.1.9. INCREASING NUMBER OF SURGERIES
 3.2. RESTRAINTS OF GLOBAL HYBRID OPERATING ROOMS MARKET
 3.2.1. HIGH COST OF OPERATING ROOM EQUIPMENT
 3.3. MARKET OPPORTUNITIES
 3.3.1. EMERGING ECONOMIES IN ASIA-PACIFIC AND LATIN AMERICA
 3.3.2. TECHNOLOGY IS THE KEY TO SUCCESS
 3.3.2.1. SURGICAL THERAPEUTICS
 3.3.2.2. ROBOTICS
 
 
CHAP 4. MARKET SEGMENTATION BY APPLICATIONS
 4.1. THERAPEUTIC
 4.1.1. CARDIOVASCULAR OR
 4.1.1.1. GLOBALLY CVD BURDENS ALMOST ALL THE REGION
 4.1.1.2. RESEARCH AND DEVELOPMENT IN CVD THERAPEUTICS
 4.1.2. NEUROSURGERY
 4.1.2.1. SOME BRANDS OF NEUROLOGICAL MONITORS
 4.1.3. THORACIC SURGERY
 4.1.4. BIOPSY
 4.1.5. ORTHOPEDIC SURGERIES
 4.1.6. LAPAROSCOPIC SURGERIES
 4.1.7. EMERGENCY CARE
 4.1.8. OTHER SURGERIES
 4.2. DIAGNOSTIC IMAGING
 4.2.1. FLUOROSCOPY 
 4.2.2. DIGITAL SUBTRACTION ANGIOGRAPHY
 4.2.3. THREE-DIMENSIONAL (3D) C-ARM COMPUTED TOMOGRAPHY
 
 
CHAP 5. MARKET SEGMENTATION BY DEVICE
 5.1. OPERATING TABLES
 5.1.1. MOBILE OPERATING TABLES
 5.1.2. STATIONARY OPERATING TABLES
 5.2. OPERATING ROOM LIGHTS
 5.2.1. DIMMABLE LIGHTS
 5.2.2. LED LIGHTING
 5.2.3. HALOGENS
 5.3. SURGICAL BOOMS
 5.4. SURGICAL IMAGING DISPLAYS
 5.5. INTRAOPERATIVE DIAGNOSTIC DEVICES
 5.5.1. 3D ULTRASOUND
 5.5.2. MRI (MAGNETIC RESONANCE IMAGING)
 5.5.2.1. TOP BRANDS AND MANUFACTURERS OF MRI
 5.5.3. COMPUTER TOMOGRAPHY
 5.5.4. COMPUTER ASSISTED ROBOTIC SURGERY
 5.5.5. C-ARM X-RAY
 5.5.6. INFRA RED IMAGING SYSTEMS
 5.6. OPERATING ROOM COMMUNICATION SYSTEMS
 5.6.1. AUDIO VISUAL
 5.6.2. OPERATING ROOM INTEGRATION SYSTEM
 5.6.2.1. WIFI
 5.6.2.2. RFID
 5.6.2.3. PACS
 
 
CHAP 6. GEOGRAPHICAL ANALYSIS
 6.1. NORTH AMERICA
 6.1.1. UNITED STATES (U.S.)
 6.1.1.1. PREVALENT DISEASES IN US 
 6.1.1.2. DIABETES IN THE US
 6.1.1.3. THE US REGULATIONS (FDA)
 6.1.2. CANADA
 6.1.2.1. DISEASES PREVALENT IN CANADA
 6.1.2.1.1. CARDIOVASCULAR DISEASES (CVD)
 6.1.2.1.2. CANCER
 6.1.2.1.3. DIABETES
 6.1.2.2. REGULATIONS IN CANADA
 6.2. EUROPE
 6.2.1. REGULATIONS REGARDING MEDICAL DEVICES IN EUROPE 
 6.2.2. PREVALENT DISEASES IN EUROPE 
 6.2.3. UNITED KINGDOM (UK) 
 6.2.3.1. DISEASES PREVALENT IN UK
 6.2.4. FRANCE
 6.2.5. GERMANY 
 6.2.5.1. DISEASES PREVALENT IN GERMANY 
 6.2.6. SPAIN 
 6.2.7. ITALY 
 6.3. ASIA PACIFIC 
 6.3.1. INDIA
 6.3.1.1. PREVALENCE OF CVD AND OTHER HEART DISEASES IN INDIA 
 6.3.1.2. REGULATIONS IN INDIA
 6.3.1.3. OPPORTUNITIES IN INDIA
 6.3.2. CHINA
 6.3.2.1. DISEASES PREVALENT IN CHINA
 6.3.2.1.1. CVD
 6.3.2.1.2. REGULATIONS IN CHINA
 6.3.3. JAPAN
 6.3.3.1. DISEASES PREVALENT IN JAPAN
 6.3.3.2. REGULATIONS IN JAPAN
 6.3.4. KOREA
 6.3.4.1. REGULATIONS IN KOREA
 6.4. REST OF THE WORLD
 6.4.1. LATIN AMERICA
 6.4.1.1. BRAZIL
 6.4.1.1.1. PREVALENT DISEASES IN BRAZIL
 6.4.1.1.2. MEXICO
 6.4.1.1.3. REGULATIONS
 6.4.1.1.4. PREVALENCE OF DISEASES IN MEXICO
 
 
CHAP 7. COMPETITIVE LANDSCAPE
 7.1. KEY STRATEGIES
 7.1.1. PARTNERSHIPS
 7.1.2. ACQUISITIONS
 7.1.3. PRODUCT LAUNCH
 
 
CHAP 8. COMPANY PROFILING
 8.1. BARCO NV
 8.1.1. OVERVIEW
 8.1.2. BARCO NV PRODUCTS PORTFOLIO IN HYBRID OR
 8.1.3. STRATEGIC MOVES
 8.1.4. SCOT ANALYSIS
 8.2. COOK MEDICAL
 8.2.1. OVERVIEW
 8.2.2. COOK MEDICAL PRODUCTS PORTFOLIO IN HYBRID OR 
 8.2.3. SCOT ANALYSIS
 8.3. ESCHMANN EQUIPMENT
 8.3.1. OVERVIEW
 8.3.2. ESCHMANN PRODUCT PORTFOLIO IN HYBRID OR
 8.3.3. SCOT ANALYSIS
 8.4. GE HEALTHCARE
 8.4.1. OVERVIEW
 8.4.2. GE HEALTHCARE PRODUCT PORTFOLIO IN HYBRID OR
 8.4.3. STRATEGIC MOVES
 8.4.4. SCOT ANALYSIS
 8.5. JOHNSON & JOHNSON
 8.5.1. OVERVIEW
 8.5.2. JOHNSON & JOHNSON PRODUCTS PORTFOLIO IN HYBRID OR
 8.5.3. SCOT ANALYSIS
 8.6. KARL STORZ GMBH & CO. KG
 8.6.1. OVERVIEW
 8.6.2. KARL STORZ PRODUCT PORTFOLIO IN HYBRID OR
 8.6.3. STRATEGIC MOVES
 8.6.4. SCOT ANALYSIS
 8.7. MAQUET GETINGE GROUP
 8.7.1. OVERVIEW
 8.7.2. MAQUET PRODUCT PORTFOLIO IN HYBRID OR
 8.7.3. STRATEGIC MOVES
 8.7.4. SCOT ANALYSIS
 8.8. MEDIFLEX
 8.8.1. OVERVIEW
 8.8.2. MEDIFLEX PRODUCT PORTFOLIO IN HYBRID OR
 8.8.3. SCOT ANALYSIS
 8.9. MIZUHO OSI
 8.9.1. OVERVIEW
 8.9.2. MIZUHO OSI PRODUCT PORTFOLIO IN HYBRID OR
 8.9.3. STRATEGIC MOVES
 8.9.4. SCOT ANALYSIS
 8.10. NDS SURGICAL IMAGING, LLC
 8.10.1. OVERVIEW
 8.10.2. NDS SURGICAL IMAGING PRODUCT PORTFOLIO IN HYBRID OR
 8.10.3. STRATEGIC MOVES
 8.10.4. SCOT ANALYSIS
 8.11. PHILIPS HEALTHCARE
 8.11.1. OVERVIEW
 8.11.2. PHILLIPS HEALTHCARE PRODUCTS PORTFOLIO IN HYBRID OR
 8.11.3. STRATEGIC MOVES
 8.11.4. SCOT ANALYSIS
 8.12. SIEMENS HEALTHCARE GMBH
 8.12.1. OVERVIEW
 8.12.2. SIEMENS HEALTHCARE PRODUCTS PORTFOLIO IN HYBRID OR
 8.12.3. STRATEGIC MOVES (2013-14)
 8.12.4. SCOT ANALYSIS
 8.13. SISCO LTD
 8.13.1. OVERVIEW
 8.13.2. SISCO PRODUCT PORTFOLIO IN HYBRID OR
 8.13.3. SCOT ANALYSIS
 8.14. SKLAR
 8.14.1. OVERVIEW
 8.14.2. SKLAR PRODUCT PORTFOLIO IN HYBRID OR
 8.14.3. SCOT ANALYSIS
 8.15. SKYTRON, LLC
 8.15.1. OVERVIEW
 8.15.2. SKYTRON PRODUCT PORTFOLIO IN HYBRID OR
 8.15.3. STRATEGIC MOVES
 8.15.4. SCOT ANALYSIS
 8.16. SONTEC INSTRUMENTS
 8.16.1. OVERVIEW
 8.16.2. SONTEC INSTRUMENTS PRODUCT PORTFOLIO IN HYBRID OR
 8.16.3. STRATEGIC MOVES
 8.16.4. SCOT ANALYSIS
 8.17. STERIS CORPORATION
 8.17.1. OVERVIEW
 8.17.2. STERIS PRODUCT PORTFOLIO IN HYBRID OR
 8.17.3. SCOT ANALYSIS
 8.18. STRYKER CORPORATION
 8.18.1. OVERVIEW
 8.18.2. STRYKER PRODUCT PORTFOLIO IN HYBRID OR
 8.18.3. STRATEGIC MOVES
 8.18.4. SCOT ANALYSIS
 8.19. TOSHIBA MEDICAL SYSTEMS
 8.19.1. OVERVIEW
 8.19.2. TOSHIBA MEDICAL SYSTEM PRODUCTS PORTFOLIO IN HYBRID OR
 8.19.3. STRATEGIC MOVES
 8.19.4. SCOT ANALYSIS
 8.20. TRUMPF GMBH + CO. KG
 8.20.1. OVERVIEW
 8.20.2. TRUMPF PRODUCT PORTFOLIO IN HYBRID OR
 8.20.3. STRATEGIC MOVES
 8.20.4. SCOT ANALYSIS
 
 
LIST OF TABLES
 
TABLE  1 GLOBAL HYBRID OPERATING ROOMS MARKET BY THERAPEUTIC APPLICATIONS IN  2014-2023 ($ BILLION) 
TABLE  4 COST OF DRUGS IN US
TABLE  5 PRICE DIFFERENCE IN INDIA AND US FOR CARDIAC RELATED SURGERIES
TABLE  6 GLOBAL HYBRID OR MARKET BY APPLICATIONS IN  2014-2023 ($ BILLION) 
TABLE  7 GLOBAL THERAPEUTIC APPLICATIONS MARKET BY TYPE IN  2014-2023 ($ BILLION) 
TABLE  8 GLOBAL THERAPEUTIC APPLICATIONS MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  9 GLOBAL CARDIOVASCULAR THERAPY MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  10 GLOBAL NEUROVASCULAR THERAPY MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  11 GLOBAL THORACIC SURGERY MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  12 GLOBAL BIOPSY MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  14 GLOBAL ORTHOPEDIC SURGERIES MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  15 GLOBAL LAPAROSCOPIC SURGERIES MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  16 GLOBAL EMERGENCY CARE MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  17 GLOBAL EMERGENCY CARE MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  18 GLOBAL DIAGNOSTIC IMAGING MARKET BY TYPE  2014-2023 ($ BILLION) 
TABLE  19 GLOBAL FLUOROSCOPY MARKET BY GEOGRAPHY  2014-2023 ($ BILLION) 
TABLE  20 GLOBAL DIGITAL SUBTRACTION ANGIOGRAPHY MARKET BY GEOGRAPHY IN $BILLION (2015-2021)
TABLE  21 GLOBAL THREE-DIMENSIONAL (3D) C-ARM COMPUTED TOMOGRAPHY MARKET BY GEOGRAPHY IN   2014-2023 ($ BILLION) 
TABLE  22 PRICELIST OF DIFFERENT CT SCANS IN US
TABLE  23 GLOBAL HYBRID OPERATING TABLE MARKET BY TYPE IN  2014-2023 ($ BILLION) 
TABLE  24 PROPERTIES REQUIRED IN AN OPERATING TABLE 
TABLE  25 GLOBAL MOBILE OPERATING TABLE MARKET BY GEOGRAPHY  2014-2023 ($ BILLION) 
TABLE  26 GLOBAL STATIONARY OPERATING TABLE MARKET BY GEOGRAPHY  2014-2023 ($ BILLION) 
TABLE  27 GLOBAL STATIONARY OPERATING ROOM LIGHTS MARKET BY GEOGRAPHY IN $BILLION (2015-2021)
TABLE  28 VARIOUS CONSIDERATIONS FOR SELECTING LIGHTING SYSTEMS FOR OPERATING ROOM
TABLE  29 GLOBAL SURGICAL BOOMS MARKET BY GEOGRAPHY  2014-2023 ($ BILLION) 
TABLE  30 GLOBAL SURGICAL IMAGE DISPLAYS MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  31 VARIOUS FACTORS TO BE CONSIDERED FOR SURGICAL DISPLAYS ARE
TABLE  32 GLOBAL INTRAOPERATIVE DIAGNOSTIC DEVICE MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  33 PRICES OF SOME OF THE BRANDED ULTRASOUND MACHINES
TABLE  34 COSTS OF VARIOUS BRANDED MRI MACHINES
TABLE  35 PRICELIST OF DIFFERENT CT SCANS IN US
TABLE  36 GLOBAL OPERATING ROOM COMMUNICATION SYSTEM MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  37 GLOBAL OPERATING ROOM COMMUNICATION SYSTEM MARKET BY TYPE IN  2014-2023 ($ BILLION) 
TABLE  38 GLOBAL HYBRID OPERATING ROOM MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION)  
TABLE  39 NORTH AMERICA HYBRID OPERATING ROOM MARKET BY GEOGRAPHY IN  2014-2023 ($ BILLION) 
TABLE  40 DIFFERENT PROCEDURES PERFORMED IN US IN 2014 
TABLE  41 CANCER PERCENTAGE IN CANADA 2014 
TABLE  42 EUROPE HYBRID OPERATING ROOM MARKET IN  2014-2023 ($ BILLION) 
TABLE  43 FATALITY IN EUROPE IN 2012 
TABLE  44 CVD STATISTICS OF THE UK IN 2014
TABLE  46 EUROPE HYBRID OPERATING ROOM MARKET IN  2014-2023 ($ BILLION) 
TABLE  47 ROW HYBRID OR MARKET IN  2014-2023 ($ BILLION)
 
LIST OF FIGURES
 
FIGURE  1 GLOBAL HYBRID OPERATING ROOM MARKET FORECAST BY REGION (2014-2023)
FIGURE  3 C-ARMS MARKET GROWTH RATE (2014-2023) 
FIGURE  4 KEY BUYING CRITERIA
FIGURE  5 STAKEHOLDERS IN THE HYBRID OPERATING ROOMS MARKET
FIGURE  6 PLANNING FOR A HYBRID OPERATING SYSTEM
FIGURE  7 MARKET DETERMINANTS OF GLOBAL HYBRID OPERATING ROOM MARKET
FIGURE  8 CONVENTIONAL VS HYBRID OPERATING ROOMS
FIGURE  10 PERCENTAGE DISTRIBUTION OF ASCS BY SPECIALITY
FIGURE  11 GLOBAL CORONARY HEART DISEASE MORTALITY RATES IN 2014
FIGURE  12 GLOBAL SMART HEALTHCARE MARKET  2014-2023 ($ BILLION) 
FIGURE  13 COST STRUCTURE FOR HYBRID OPERATING ROOM INSTALLATION (%) 
FIGURE  14 GLOBAL CARDIOVASCULAR THERAPY MARKET  2014-2023 ($ BILLION) 
FIGURE  15 POPULATION AFFECTED IN LOW-MIDDLE INCOME COUNTRIES IN 2012 
FIGURE  16 PERCENTAGE OF CVD IN 2012 
FIGURE  17 GLOBAL NEUROSURGERY THERAPY MARKET  2014-2023 ($ BILLION) 
FIGURE  18 GLOBAL THORACIC SURGERY MARKET  2014-2023 ($ BILLION) 
FIGURE  19 GLOBAL BIOPSY MARKET  2014-2023 ($ BILLION) 
FIGURE  20 ADVANTAGES AND RISK OF BIOPSY 
FIGURE  21 GLOBAL ORTHOPEDIC SURGERIES MARKET  2014-2023 ($ BILLION) 
FIGURE  22 GLOBAL LAPAROSCOPIC SURGERIES MARKET  2014-2023 ($ BILLION) 
FIGURE  23 BENEFITS OF LAPAROSCOPIC SURGERY
FIGURE  24 GLOBAL FLUOROSCOPY MARKET BY  2014-2023 ($ BILLION) 
FIGURE  25 ADVANTAGES OF FLUOROSCOPY 
FIGURE  26 CT SCANS AND ITS BENEFITS 
FIGURE  27 WIRELESS APPLICATIONS AND TECHNOLOGIES IN HOSPITAL SUPPORT 
FIGURE  29 CVD PREVALENCE IN CANADA 
FIGURE  30 FATALITIES DUE TO CVD IN 2014

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion